Status:
COMPLETED
Clinical and Economic Implications of Genetic Testing for Warfarin Management
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Blood Coagulation Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether pr...
Detailed Description
The overall goal of this project is to develop and assess the effectiveness and cost-effectiveness of strategies that use genetic testing in the management of anticoagulation among racially diverse ho...
Eligibility Criteria
Inclusion
- warfarin-naive patients
- ages 18 and older
- are undergoing inpatient anticoagulation initiation with warfarin for diagnoses that necessitate anticoagulation
Exclusion
- patients who are not warfarin-naive
- 17 years of age or younger
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
359 Patients enrolled
Trial Details
Trial ID
NCT00964353
Start Date
August 1 2009
End Date
April 1 2014
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637